Trial Profile
Safety and efficacy of glinide for the treatment of type 2 diabetic patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2013
Price :
$35
*
At a glance
- Drugs Mitiglinide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Oct 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 08 May 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Jan 2011 New trial record